Literature DB >> 10811640

Human lactoferrin binds and removes the hemoglobin receptor protein of the periodontopathogen Porphyromonas gingivalis.

Y Shi1, W Kong, K Nakayama.   

Abstract

Porphyromonas gingivalis possesses a hemoglobin receptor (HbR) protein on the cell surface as one of the major components of the hemoglobin utilization system in this periodontopathogenic bacterium. HbR is intragenically encoded by the genes of an arginine-specific cysteine proteinase (rgpA), lysine-specific cysteine proteinase (kgp), and a hemagglutinin (hagA). Here, we have demonstrated that human lactoferrin as well as hemoglobin have the abilities to bind purified HbR and the cell surface of P. gingivalis through HbR. The interaction of lactoferrin with HbR led to the release of HbR from the cell surface of P. gingivalis. This lactoferrin-mediated HbR release was inhibited by the cysteine proteinase inhibitors effective to the cysteine proteinases of P. gingivalis. P. gingivalis could not utilize lactoferrin for its growth as an iron source and, in contrast, lactoferrin inhibited the growth of the bacterium in a rich medium containing hemoglobin as the sole iron source. Lactoferricin B, a 25-amino acid-long peptide located at the N-lobe of bovine lactoferrin, caused the same effects on P. gingivalis cells as human lactoferrin, indicating that the effects of lactoferrin might be attributable to the lactoferricin region. These results suggest that lactoferrin has a bacteriostatic action on P. gingivalis by binding HbR, removing it from the cell surface, and consequently disrupting the iron uptake system from hemoglobin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811640     DOI: 10.1074/jbc.M001518200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Porphyrin-mediated cell surface heme capture from hemoglobin by Porphyromonas gingivalis.

Authors:  Mayuri Paramaesvaran; Ky-Anh Nguyen; Elizabeth Caldon; James A McDonald; Sherean Najdi; Graciel Gonzaga; David B Langley; Arthur DeCarlo; Maxwell J Crossley; Neil Hunter; Charles A Collyer
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

2.  Lactoferrin inhibits Porphyromonas gingivalis proteinases and has sustained biofilm inhibitory activity.

Authors:  Stuart G Dashper; Yu Pan; Paul D Veith; Yu-Yen Chen; Elena C Y Toh; Sze Wei Liu; Keith J Cross; Eric C Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

3.  Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.

Authors:  Hiroyuki Wakabayashi; Koji Yamauchi; Tetsuo Kobayashi; Tomoko Yaeshima; Keiji Iwatsuki; Hiromasa Yoshie
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

4.  IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin.

Authors:  Simon R Clarke; Simon J Foster
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

5.  Effects of orally administered lactoferrin and lactoperoxidase-containing tablets on clinical and bacteriological profiles in chronic periodontitis patients.

Authors:  Eiju Shimizu; Tetsuo Kobayashi; Hiroyuki Wakabayashi; Koji Yamauchi; Keiji Iwatsuki; Hiromasa Yoshie
Journal:  Int J Dent       Date:  2011-04-03

6.  Effect of deletion of the rgpA gene on selected virulence of Porphyromonas gingivalis.

Authors:  Rui Zhang; Jie Yang; Juan Wu; Wei-Bin Sun; Yu Liu
Journal:  J Dent Sci       Date:  2016-04-18       Impact factor: 2.080

7.  Propeptide-mediated inhibition of cognate gingipain proteinases.

Authors:  N Laila Huq; Christine A Seers; Elena C Y Toh; Stuart G Dashper; Nada Slakeski; Lianyi Zhang; Brent R Ward; Vincent Meuric; Dina Chen; Keith J Cross; Eric C Reynolds
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

8.  Effects of orally administered lactoferrin and lactoperoxidase on symptoms of the common cold.

Authors:  Kouichirou Shin; Hiroyuki Wakabayashi; Chihiro Sugita; Hiroki Yoshida; Keizo Sato; Tohru Sonoda; Koji Yamauchi; Fumiaki Abe; Masahiko Kurokawa
Journal:  Int J Health Sci (Qassim)       Date:  2018 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.